130 related articles for article (PubMed ID: 37683535)
1. Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis.
Liao J; Zhang Y; Huang M; Liang Z; Gong Y; Liu B; Li Y; Chen J; Wu W; Huang Z; Sun J
Bioorg Chem; 2023 Nov; 140():106837. PubMed ID: 37683535
[TBL] [Abstract][Full Text] [Related]
2. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
[TBL] [Abstract][Full Text] [Related]
3. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
Xiong K; Chen Y; Ouyang C; Guan RL; Ji LN; Chao H
Biochimie; 2016 Jun; 125():186-94. PubMed ID: 27039888
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
7. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
8. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Ir
Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW
Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells.
Chen Y; Gu Y; Hu H; Liu H; Li W; Huang C; Chen J; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112134. PubMed ID: 36706490
[TBL] [Abstract][Full Text] [Related]
11. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
[TBL] [Abstract][Full Text] [Related]
12. Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP.
Xiong X; Huang KB; Wang Y; Cao B; Luo Y; Chen H; Yang Y; Long Y; Liu M; Chan ASC; Liang H; Zou T
J Am Chem Soc; 2022 Jun; 144(23):10407-10416. PubMed ID: 35658433
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria.
Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y
J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300
[TBL] [Abstract][Full Text] [Related]
14. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
15. Cyclometalated Iridium(III) Complex-Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca
Balachandran C; Yokoi K; Naito K; Haribabu J; Tamura Y; Umezawa M; Tsuchiya K; Yoshihara T; Tobita S; Aoki S
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834120
[TBL] [Abstract][Full Text] [Related]
16. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity in vitro and in vivo evaluation of iridium(III) complexes on mouse melanoma B16 cells.
Yuan Y; Shi C; Wu X; Li W; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Jul; 232():111820. PubMed ID: 35421766
[TBL] [Abstract][Full Text] [Related]
19. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents.
Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y
Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
